Publications by authors named "Rafael Amigot-Sanchez"

Article Synopsis
  • Hepatitis C virus (HCV) microelimination focuses on detecting and treating hidden infections in vulnerable populations, particularly people experiencing homelessness (PEH) who may suffer from substance use disorders, highlighting the role of point-of-care testing and peer support in infection prevention.
  • A study conducted in Madrid from 2019 to 2023 assessed active HCV infection among PEH, utilizing rapid testing methods and analyzing various risk factors, including substance use and financial instability.
  • Out of 2,709 screened PEH, 13.4% tested positive for HCV antibodies, with a prevalence of 6.3% for active infection; key risk factors identified were injection drug use (IDU) and associated behaviors, leading to
View Article and Find Full Text PDF

Dried blood spot (DBS) sampling is increasingly used for hepatitis C virus (HCV) screening. HCVcAg testing offers a faster and more streamlined approach to diagnosing HCV infection. We conducted a systematic review and meta-analysis to assess the diagnostic performance of the Abbott ARCHITECT HCV Ag assay for screening active HCV infection using DBS samples.

View Article and Find Full Text PDF

This study evaluated titers and amplitudes of anti-E2 antibodies (anti-E2-Abs) and neutralizing antibodies against hepatitis C virus (HCV; anti-HCV-nAbs) in HIV/HCV-coinfected individuals over five years after successful HCV treatment completion. We retrospectively analyzed 76 HIV/HCV-coinfected patients achieving sustained virologic response post-HCV treatment. Plasma levels of anti-E2-Abs and anti-HCV-nAbs against five HCV genotypes (Gt1a, Gt1b, Gt2a, Gt3a, and Gt4a) were determined using ELISA and microneutralization assays, respectively.

View Article and Find Full Text PDF
Article Synopsis
  • A study in Madrid, Spain, assessed the trends and risk factors of active hepatitis C virus (HCV) infections among people who use drugs (PWUD) from 2017 to 2023, involving 2,264 participants and extensive data collection.
  • Results showed a significant decline in active HCV infection rates from 23.4% to 6.0% in the overall study population, with a notable reduction among those who inject drugs (PWID) and non-injectors.
  • The findings indicate successful prevention and treatment efforts in Madrid, particularly benefiting PWID, highlighting the effectiveness of public health initiatives in controlling HCV infection rates.
View Article and Find Full Text PDF

Objectives: We aimed to analyze whether the expression of inflammatory and antiviral genes in respiratory syncytial virus (RSV)-infected infants' peripheral blood is associated with bronchiolitis progression.

Methods: We conducted a prospective study on 117 infants between 2015 and 2023. The expression levels of nine genes were quantified by quantitative polymerase chain reaction.

View Article and Find Full Text PDF

Fungal ribotoxins are extracellular RNases that inactivate ribosomes by cleaving a single phosphodiester bond at the universally conserved sarcin-ricin loop of the large rRNA. However, to reach the ribosomes, they need to cross the plasma membrane. It is there where these toxins show their cellular specificity, being especially active against tumoral or virus-infected cells.

View Article and Find Full Text PDF

Despite highly effective treatments to cure hepatitis C, almost 80% of chronically HCV-infected people are not treated, as they are unaware of their infection. Diagnostic rates and linkage to care must be substantially improved to reverse this situation. The HCV core antigen (HCVcAg) is a highly conserved protein that can be detected in the blood of HCV-infected patients and indicates active infection.

View Article and Find Full Text PDF

Actinoporins are pore-forming toxins produced by sea anemones. They exert their activity by binding to the membranes of target cells. There, they oligomerize, forming cation-selective pores, and inducing cell death by osmotic shock.

View Article and Find Full Text PDF

Sticholysins are α-pore-forming toxins produced by the sea-anemone Stichodactyla helianthus. These toxins exert their activity by forming pores on sphingomyelin-containing membranes. Recognition of sphingomyelin by sticholysins is required to start the process of pore formation.

View Article and Find Full Text PDF

Spanish or Spanish-speaking scientists represent a remarkably populated group within the scientific community studying pore-forming proteins. Some of these scientists, ourselves included, focus on the study of actinoporins, a fascinating group of metamorphic pore-forming proteins produced within the venom of several sea anemones. These toxic proteins can spontaneously transit from a water-soluble fold to an integral membrane ensemble because they specifically recognize sphingomyelin in the membrane.

View Article and Find Full Text PDF

Sticholysins are pore-forming toxins produced by the sea anemone Stichodactyla helianthus. When they encounter a sphingomyelin-containing membrane, these proteins bind to it and oligomerize, a process that ends in pore formation. Mounting evidence indicates that StnII can favour the activity of StnI.

View Article and Find Full Text PDF